We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$474M
AUM Growth
+$427M
(+909%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
91.18%
Top 10 Holdings %
Top 10 Hldgs %
10.55%
Holding
454
New
296
Increased
64
Reduced
55
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OXLC
Oxford Lane Capital
OXLC
|
+$6.86M |
| 2 |
Barings BDC
BBDC
|
+$6.33M |
| 3 |
Oxford Square Capital
OXSQ
|
+$5.45M |
| 4 |
ECC
Eagle Point Credit Company
ECC
|
+$5.29M |
| 5 |
FS KKR Capital
FSK
|
+$5.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$2.25M |
| 2 |
ACOR
Acorda Therapeutics
ACOR
|
+$644K |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$605K |
| 4 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
+$603K |
| 5 |
uniQure
QURE
|
+$374K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.58% |
| 2 | Real Estate | 14.99% |
| 3 | Energy | 13.55% |
| 4 | Healthcare | 12.23% |
| 5 | Materials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Sempra
SRE
$60.8B
| $13K | ﹤0.01% |
+196
| New | +$12.9K |
|
402
TAL Education Group
TAL
$5.71B
| $13K | ﹤0.01% |
+329
| New | +$11.9K |
|
403
Western Digital
WDC
$179B
| $13K | ﹤0.01% |
+361
| New | +$12.4K |
|
404
C.H. Robinson
CHRW
$22B
| $12K | ﹤0.01% |
144
-60
| -29% | -$5.05K |
|
405
CMS Energy
CMS
$23.1B
| $12K | ﹤0.01% |
+214
| New | +$12K |
|
406
Lamb Weston
LW
$6.82B
| $12K | ﹤0.01% |
+191
| New | +$12.6K |
|
407
Medtronic
MDT
$107B
| $12K | ﹤0.01% |
121
| – | – |
|
408
Realty Income
O
$61.2B
| $12K | ﹤0.01% |
+181
| New | +$12.4K |
|
409
Simon Property Group
SPG
$74.5B
| $12K | ﹤0.01% |
+77
| New | +$13.3K |
|
410
Yum China
YUMC
$14.9B
| $12K | ﹤0.01% |
262
-16
| -6% | -$695 |
|
|
CTXS
411
DELISTED
Citrix Systems Inc
CTXS
| $12K | ﹤0.01% |
+125
| New | +$12.3K |
|
|
VIAB
412
DELISTED
Viacom Inc. Class B
VIAB
| $12K | ﹤0.01% |
407
| – | – |
|
|
SBNY
413
DELISTED
Signature Bank
SBNY
| $12K | ﹤0.01% |
101
| – | – |
|
414
Align Technology
ALGN
$12B
| $11K | ﹤0.01% |
+41
| New | +$12.4K |
|
415
Corning
GLW
$126B
| $11K | ﹤0.01% |
+320
| New | +$10.3K |
|
416
H&R Block
HRB
$5.18B
| $11K | ﹤0.01% |
+385
| New | +$10.3K |
|
417
Kohl's
KSS
$2.03B
| $11K | ﹤0.01% |
+239
| New | +$14.4K |
|
|
TTM
418
DELISTED
Tata Motors Limited
TTM
| $11K | ﹤0.01% |
+944
| New | +$12.8K |
|
419
Brighthouse Financial
BHF
$3.63B
| $10K | ﹤0.01% |
+261
| New | +$10.1K |
|
420
Macy's
M
$6.15B
| $10K | ﹤0.01% |
452
| – | – |
|
421
VF Corp
VFC
$6.68B
| $10K | ﹤0.01% |
+118
| New | +$10.2K |
|
422
Procter & Gamble
PG
$343B
| $9K | ﹤0.01% |
+81
| New | +$8.63K |
|
423
Amphenol
APH
$188B
| $8K | ﹤0.01% |
+340
| New | +$8.18K |
|
424
Berkshire Hathaway Class B
BRK.B
$1.07T
| $8K | ﹤0.01% |
+38
| New | +$7.86K |
|
425
KT
KT
$8.84B
| $7K | ﹤0.01% |
566
+270
| +91% | +$3.29K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, Virtus ETF Advisers held 454 positions worth $474M, up 909% from $47M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Virtus ETF Advisers deployed $433M of net new capital in Q2 2019, opening 296 new positions and adding to 64 existing holdings. Its largest new stake was Oxford Lane Capital: 132,284 shares worth $6.67M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 0.73% a quarter earlier, followed by Real Estate and Energy.
On the sell side, the largest reduction was Array Biopharma Inc, an estimated $605K trimmed.
- Virtus ETF Advisers's largest Q2 2019 buy was Oxford Lane Capital: 132,284 shares worth $6.67M.
- Virtus ETF Advisers added most to Dominion Energy in Q2 2019, an estimated $2.63M increase.
- Virtus ETF Advisers's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $605K.
- Virtus ETF Advisers fully exited Spark Therapeutics, Inc. Common Stock in Q2 2019, selling an estimated $2.25M.
- Virtus ETF Advisers's ten largest holdings make up 11% of its $474M portfolio in Q2 2019.
- Virtus ETF Advisers opened 296 new positions and closed 20 in Q2 2019.
- Virtus ETF Advisers's portfolio value rose 909% quarter-over-quarter to $474M.
Based on Virtus ETF Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.